{
  "title": "Systems Biology Approach to Analysis of 2010-11 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY301, SDY296)",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY74",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Systems Biology Approach to Analysis of 2010-11 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY301, SDY296)",
  "performedBy": [
    {
      "firstName": "A. Karolina",
      "lastName": "Palucka",
      "email": "karolinap@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Research Institute"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Influenza",
          "size": 12
        }
  ],
  
  "usesReagent": [
        {
          "name": "FLOW_DC_COCKTAIL"
        },
        {
          "name": "FLOW_CD4_COCKTAIL"
        },
        {
          "name": "FLOW_MONO_COCKTAIL"
        },
        {
          "name": "FLOW_B_COCKTAIL"
        },
        {
          "name": "GX-BeadChip HT12v4"
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "A. Karolina",
      "lastName": "Palucka",
      "email": "karolinap@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Research Institute"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI089987"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Our goal is to identify early biomarkers of effective antibody responses to flu vaccination. Four aims are proposed to meet this goal: Aim 1: To establish the baseline immune profiles in healthy subjects. Aim 2: To establish the immune profiles of Flu vaccination in healthy subjects. Aim 3: To identify the molecular signatures of DC subset(s) in response to Flu vaccination. Aim 4: To identify the molecular signatures of activated monocytes in response to Flu vaccination. RELEVANCE (See instructions): Despite the success of vaccines, we understand little about how effective ones stimulate protective immune responses. We will study how the flu vaccine generates effective antibody responses. The goal is to identify the immune responses elicited by effective vaccines so that vaccines that aren't as effective can be improved. To do this, we will vaccinate healthy people with the flu vaccine and monitor their immune response following the vaccination.   http://projectreporter.nih.gov/project_info_details.cfm?aid=8691692&icde=23828587&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "23486778",
          "identifierSource": "pubmed"
        },
      "authorsList": "Bentebibel SE(1), Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, Flano E,  Mejias A, Albrecht RA, Blankenship D, Xu H, Pascual V, Banchereau J, Garcia-Sastre A, Palucka AK, Ramilo O, Ueno H.",
      "title": "Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination.",
      "publicationVenue": "Sci Transl Med.",
      "dates": [
        {
          "date": "2013",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Interventional"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2010-01-01",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2016-02-05",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cellular Phenotype"
        },
        "description": "None",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Blood Cell Count with Differential"
        }
      },{
        "name": {
            "value": "Chemistry Test"
        }
      },{
        "name": {
            "value": "Vitals"
        }
      }
      
  ],
  "isAbout": [
        {
          "name": "SDY74-Microarray"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY74",
              "identifierSource": "ImmPort"
          },
          "title": "Systems Biology Approach to Analysis of 2010-11 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY301, SDY296)",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY74",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8259851&icde=23826717&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "This study will measure the immune response to the influenza vaccine  The long-term goal is to develop improved vaccines to infectious diseases such as influenza. Blood will be collected from patients at several visits before and after vaccination. The blood will be used in a series of immunological tests to measure the strength and breadth of immune response. These assays may include T cell and B cell activation assays, microarray testing, Epimax, Epigen, and flow cytometry."
}
